Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA’s Office Of Regulatory Affairs Scrutinizes Recalls Process

This article was originally published in The Gray Sheet

Executive Summary

Improving the efficiency of the recall process is one of ORA’s priorities for fiscal 2012. And CDRH says its own recall improvements efforts are starting to bear fruit.

You may also be interested in...

Senate Bill Would Allow 510(k) Condition-Of-Clearance Studies

Legislation introduced Dec. 15 would give FDA PMA-like authorities over 510(k) devices, including the power to require post-clearance studies. Industry says the bill is unnecessary.

GAO Calls For Reforms In FDA Oversight Of Device Recalls

The Government Accountability Office is urging FDA to clarify and strengthen its oversight of medical device recalls.

Device Center Launches Recalls Improvement Team

FDA's device center has formed a new team to improve the way medical device recalls are carried out and communicated to the public.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts